CRSP

CRISPR Therapeutics AG

May 19 • 03:21PM ET

47.58

-0.98 -2.02 %

Healthcare • Biotechnology • Switzerland • Mid • NASD

Peers: NTLA BEAM EDIT PRME VRTX

| Held by: ARKK IWM ARKG XBI VXF IWN IBB VTWO SCHA SCHM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-6.21	Insider Own	7.15%	Shs Outstand	96.39M	Perf Week	-9.94%
Market Cap	4.59B	Forward P/E	-	EPS next Y	-3.83	Insider Trans	-3.21%	Shs Float	89.55M	Perf Month	-17.52%
Enterprise Value	2.93B	PEG	-	EPS next Q	-1.17	Inst Own	72.77%	Short Float	25.11%	Perf Quarter	-11.10%
Income	-568.53M	P/S	1119.28	EPS this Y	25.28%	Inst Trans	4.24%	Short Ratio	11.80	Perf Half Y	-9.42%
Sales	4.10M	P/B	2.53	EPS next Y	20.84%	ROA	-23.24%	Short Interest	22.48M	Perf YTD	-9.27%
Book/sh	18.83	P/C	1.88	EPS next 5Y	28.01%	ROE	-31.21%	52W High	78.48 -39.37%	Perf Year	23.01%
Cash/sh	25.32	P/FCF	-	EPS past 3/5Y	8.21% -4.10%	ROIC	-22.01%	52W Low	35.38 34.48%	Perf 3Y	-23.42%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	43.09% 37.31%	Gross Margin	-5283.40%	Volatility	4.43% 5.38%	Perf 5Y	-56.96%
Dividend TTM	-	EV/Sales	715.73	EPS Y/Y TTM	-37.55%	Oper. Margin	-13408.29%	ATR (14)	2.66	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	17.96	Sales Y/Y TTM	-89.11%	Profit Margin	-13856.54%	RSI (14)	39.16	Recom	1.93
Dividend Gr. 3/5Y	- -	Current Ratio	17.96	EPS Q/Q	19.13%	SMA20	-8.59%	Beta	1.72	Target Price	79.17
Payout	-	Debt/Eq	0.43	Sales Q/Q	68.55%	SMA50	-6.84%	Rel Volume	0.72	Prev Close	48.56
Employees	-	LT Debt/Eq	0.42	Earnings	May 04 AMC	SMA200	-14.82%	Avg Volume	1.90M	Price	47.58
IPO	Oct 19, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	-5.05% -75.96%	Trades		Volume	1,240,741	Change	-2.02%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)